5-års totaloverlevelse for plateepitelkarsinom
Basert på FIGO stadium (Beller et al., 2006; FIGO (International Federation of Gynecology and Obstetrics) 26th Annual Report on the Results of Treatment in Gynecological Cancer, 2006)
- Stadium I : 90 % (Ia 98 %, Ib 88 %)
- Stadium II: 81 %
- Stadium III: 68 %
- Stadium IV: 20 %
- Residiv: 25–35 %
5-års overlevelse for ikke-plateepitel vulvacancer
- Bartholini cancer 64,5 % (Beller et al., 2006; FIGO (International Federation of Gynecology and Obstetrics) 26th Annual Report on the Results of Treatment in Gynecological Cancer, 2006)
- Melanom 61,9 %
- Adenokarsinom 32,5 %